Sahpra recalls Arya Pharma’s high blood pressure meds, Enalapril

Image credit: Arya Pharma

Arya Pharma is implementing the Class II Type A recall in consultation with Sahpra, in accordance with the Medicines and Related Substances Act 101 of 1965, as amended.

Sahpra has urged patients, healthcare professionals, pharmacies, wholesalers and other medicine suppliers to immediately check their stock, identify any affected batches and take the necessary action in line with the recall.

Enalapril is used to manage high blood pressure. Sahpra has asked patients currently taking Enalapril 10 mg Arya to check the batch number on their medicine packaging to determine whether their medicine is affected.

Patients who have one of the affected batches have been advised to contact their pharmacist or healthcare professional for advice and, where necessary, to request an alternative medicine.

Novo Nordisk v iDexis: What’s in a name (or, in this case, a compounded medicine)?

24 Jul 2026

Sahpra added that patients should not stop taking their blood-pressure medication without first consulting their doctor, pharmacist or another healthcare professional.

Sahpra emphasised that the recall applies only to the four identified batches.

Healthcare professionals, pharmacies, wholesalers and other medicine suppliers are requested to:

• Immediately identify stock from the affected batches.
  
• Stop dispensing, selling or distributing the affected batches and quarantine affected stock.
  
• Return affected stock through the established supply chain in accordance with the recall instructions issued by Arya Pharma (Pty) Ltd.